###begin article-title 0
MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages
###end article-title 0
###begin p 1
###xml 138 159 138 159 <email xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">rick.maizels@ed.ac.uk</email>
 Correspondence: Institute of Immunology and Infection Research, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK. E-mail: rick.maizels@ed.ac.uk
###end p 1
###begin p 2
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 588 601 588 601 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia malayi</italic>
###xml 693 699 693 699 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 1296 1302 1288 1294 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 1504 1510 1492 1498 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 588 601 <span type="species:ncbi:6279">Brugia malayi</span>
###xml 649 654 <span type="species:ncbi:10090">mouse</span>
###xml 671 677 <span type="species:ncbi:10090">murine</span>
###xml 767 772 <span type="species:ncbi:10090">mouse</span>
###xml 1120 1126 <span type="species:ncbi:10090">murine</span>
Macrophage migration inhibitory factor (MIF) is a highly conserved cytokine considered to exert wide-ranging, proinflammatory effects on the immune system. Recently, members of this gene family have been discovered in a number of invertebrate species, including parasitic helminths. However, chronic helminth infections are typically associated with a Th2-dominated, counter-inflammatory phenotype, in which alternatively activated macrophages (AAMs) are prominent. To resolve this apparent paradox, we have analyzed the activity of two helminth MIF homologues from the filarial nematode Brugia malayi, in comparison with the canonical MIF from the mouse. We report that murine MIF (mMIF) and Brugia MIF proteins induce broadly similar effects on bone marrow-derived mouse macrophages, eliciting a measured release of proinflammatory cytokines. In parallel, MIF was found to induce up-regulation of IL-4R on macrophages, which when treated in vitro with MIF in combination with IL-4, expressed markers of alternative activation [arginase, resistin-like molecule alpha (RELM-alpha) or found in inflammatory zone 1, Ym-1, murine macrophage mannose receptor] and differentiated into functional AAMs with in vitro-suppressive ability. Consistent with this finding, repeated in vivo administration of Brugia MIF induced expression of alternative macrophage activation markers. As mMIF did not induce RELM-alpha or Ym-1 in vivo, alternative activation may require components of the adaptive immune response to Brugia MIF, such as the production of IL-4. Hence, MIF may accentuate macrophage activation according to the polarity of the environment, thus promoting AAM differentiation in the presence of IL-4-inducing parasitic helminths.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 209 210 209 210 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B1" ref-type="bibr">1</xref>
###xml 212 213 212 213 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B2" ref-type="bibr">2</xref>
###xml 360 361 360 361 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B3" ref-type="bibr">3</xref>
###xml 363 364 363 364 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B4" ref-type="bibr">4</xref>
###xml 536 537 536 537 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B5" ref-type="bibr">5</xref>
###xml 549 550 549 550 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B3" ref-type="bibr">3</xref>
###xml 570 571 570 571 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B6" ref-type="bibr">6</xref>
###xml 631 632 631 632 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B7" ref-type="bibr">7</xref>
Mammalian migration inhibitory factor (MIF) was among the first immune system cytokines to be discovered as a soluble factor released from activated lymphocytes that inhibited random migration of macrophages [1, 2]. The designation of macrophage MIF has endured, although MIF is now recognized as being highly pleiotropic in regulation of innate and adaptive [3, 4] immune cell populations, as well as cells of the neuroendocrine system. Equally, MIF is notable for its production by a wide range of cell types, locally by macrophages [5], T cells [3], and eosinophils [6], as well as systemically by the anterior pituitary gland [7].
###end p 5
###begin p 6
###xml 104 105 104 105 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B8" ref-type="bibr">8</xref>
###xml 107 108 107 108 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B9" ref-type="bibr">9</xref>
###xml 314 315 310 311 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B7" ref-type="bibr">7</xref>
###xml 353 356 349 352 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">o/o</sup>
###xml 444 446 440 442 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B10" ref-type="bibr">10</xref>
###xml 463 466 459 462 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">o/o</sup>
###xml 546 548 542 544 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B11" ref-type="bibr">11</xref>
###xml 767 769 763 765 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B12" ref-type="bibr">12</xref>
###xml 771 773 767 769 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B13" ref-type="bibr">13</xref>
###xml 905 907 901 903 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B14" ref-type="bibr">14</xref>
###xml 917 920 913 916 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">o/o</sup>
###xml 949 971 945 967 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella typhimurium</italic>
###xml 983 985 979 981 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B15" ref-type="bibr">15</xref>
###xml 1056 1072 1052 1068 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Leishmania major</italic>
###xml 1074 1076 1070 1072 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B16" ref-type="bibr">16</xref>
###xml 1093 1110 1089 1106 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Taenia crassiceps</italic>
###xml 1112 1114 1108 1110 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B17" ref-type="bibr">17</xref>
###xml 1223 1225 1219 1221 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B18" ref-type="bibr">18</xref>
###xml 1375 1377 1371 1373 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B19" ref-type="bibr">19</xref>
###xml 1456 1458 1452 1454 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B20" ref-type="bibr">20</xref>
###xml 1458 1460 1454 1456 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B21" ref-type="bibr">21</xref>
###xml 1460 1462 1456 1458 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B22" ref-type="bibr">22</xref>
###xml 1462 1464 1458 1460 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B23" ref-type="bibr">23</xref>
###xml 1464 1466 1460 1462 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B24" ref-type="bibr">24</xref>
###xml 215 220 <span type="species:ncbi:9606">human</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 949 971 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 1056 1072 <span type="species:ncbi:5664">Leishmania major</span>
###xml 1093 1110 <span type="species:ncbi:6207">Taenia crassiceps</span>
There are compelling data from a variety of systems that MIF acts in a strongly proinflammatory manner [8, 9]. In vitro, exogenous MIF elicits the release of IL-6, IL-8, TNF-alpha, and endogenous MIF secretion from human monocytes and mouse macrophages. In vivo, MIF synergizes with LPS to accentuate toxic shock [7]. Most strikingly, MIF deficient (MIFo/o) mice survive the normally lethal administration of LPS or staphylococcal enterotoxin [10]. Similarly, MIFo/o animals do not succumb to 2,4,6-trinitrobenzene sulfonic acid-induced colitis [11], demonstrating that MIF is required in sustained inflammatory disease as well as in the acute setting of septic shock. Not only Th1-type but also Th2-dominated allergic responses are diminished in the absence of MIF [12, 13], which may be essential in resistance to bacterial infection. Not only does it up-regulate innate pattern receptors such as TLR4 [14], but MIFo/o mice die following low-dose Salmonella typhimurium infection [15]. The same MIF-deficient animals are more susceptible to a protozoan (Leishmania major [16]) and helminth (Taenia crassiceps [17]) infection, albeit a helminth infection where parasite clearance is mediated by proinflammatory cytokines [18]. Against this background of a spectrum of immune reactivities promoted by MIF, it is perhaps suprising that many tumors also produce this cytokine [19], and in the setting of cancer, MIF may act in an immunosuppressive capacity [2021222324].
###end p 6
###begin p 7
###xml 82 84 82 84 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B25" ref-type="bibr">25</xref>
###xml 175 177 175 177 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B26" ref-type="bibr">26</xref>
###xml 317 319 317 319 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B25" ref-type="bibr">25</xref>
###xml 373 375 373 375 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B27" ref-type="bibr">27</xref>
###xml 477 479 477 479 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B28" ref-type="bibr">28</xref>
###xml 555 556 555 556 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B4" ref-type="bibr">4</xref>
###xml 558 560 558 560 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B29" ref-type="bibr">29</xref>
###xml 562 564 562 564 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B30" ref-type="bibr">30</xref>
###xml 672 674 672 674 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B31" ref-type="bibr">31</xref>
###xml 674 676 674 676 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B32" ref-type="bibr">32</xref>
###xml 676 678 676 678 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B33" ref-type="bibr">33</xref>
###xml 868 870 868 870 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B34" ref-type="bibr">34</xref>
###xml 1050 1052 1050 1052 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B35" ref-type="bibr">35</xref>
###xml 1199 1201 1199 1201 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B30" ref-type="bibr">30</xref>
###xml 1326 1328 1326 1328 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B22" ref-type="bibr">22</xref>
MIF has two unusual biochemical properties. First, it encodes no signal sequence [25] but is secreted by an alternative route requiring an ABC-containing transporter protein [26]. Second, MIF is unique in combining cell-stimulatory activity (cytokine) with two enzymatic activities within a relatively small protein [25], namely a tautomerase, which is dependent on Pro-2 [27], and an oxidoreductase, dependent on cysteine residues 57 and 60, forming a thioredoxin-like motif [28]. The signaling pathway for MIF-induced effects has proven more enigmatic [4, 29, 30]. CD74 (invariant chain) is one receptor for MIF that can, via CD44, activate intracellular MAPK pathways [313233]. MIF can also bind the chemokine receptors CXCR2 and CXCR4, which are expressed on many CD74-negative cell types, linking it more closely to chronic inflammation such as artherosclerosis [34]. However, in the cytoplasm, MIF also binds c-Jun activation domain-binding protein-1 (Jab1), preventing the latter from activating the proinflammatory transcription factor AP-1 [35]. Hence, in some circumstances, MIF can exert an anti-inflammatory effect. Although this activity may require relatively high MIF concentrations [30], studies on tumors have suggested that immune evasion results, directly or indirectly, from high levels of MIF production [22].
###end p 7
###begin p 8
###xml 121 123 121 123 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B36" ref-type="bibr">36</xref>
###xml 125 127 125 127 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B37" ref-type="bibr">37</xref>
###xml 198 211 198 211 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia malayi</italic>
###xml 245 251 245 251 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 253 255 253 255 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 341 343 341 343 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B38" ref-type="bibr">38</xref>
###xml 345 347 345 347 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 530 536 530 536 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 871 873 867 869 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 966 972 962 968 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 1053 1055 1049 1051 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1201 1203 1197 1199 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 1249 1251 1245 1247 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1259 1261 1255 1257 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 1291 1293 1287 1289 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B40" ref-type="bibr">40</xref>
###xml 1384 1386 1380 1382 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1514 1516 1510 1512 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1562 1564 1558 1560 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 198 211 <span type="species:ncbi:6279">Brugia malayi</span>
###xml 712 717 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
In this context, the discovery of MIF secreted by parasites, which establish a broadly counter-inflammatory environment [36, 37], is particularly intriguing. Thus, in the filarial nematode parasite Brugia malayi, two MIF homologues are present, Brugia (Bm)-MIF-1 and -2, with, respectively, 40% and 27% identity with the mammalian proteins [38, 39]. As these levels of amino acid identity were relatively low, it was possible that the parasite homologues were functionally different from the mammalian ones. We therefore compared Brugia and mammalian MIFs, to test whether parasite proteins would antagonize the mammalian ones or even stimulate host cells in a different way altogether. Surprisingly, tests with human monocytes showed that like human MIF (hMIF), parasite MIF proteins induce a proinflammatory profile of cytokines such as TNF-alpha, IL-8, and even hMIF [39]. Thus, parasite MIF induces host cells to release more MIF of endogenous origin. Moreover, Brugia MIFs were found to be biochemically and structurally similar to mammalian MIFs. Bm-MIF-1/2 have high levels of dopachrome tautomerase enzyme activity, although some significant differences in substrate preference were observed [39]. The three-dimensional crystal structure of Bm-MIF-2 [39], like that of hookworm MIF [40], is remarkably similar between host and parasite molecules. It should also be noted that Bm-MIF-2 has neither the Cys-57 nor -60 associated with oxidoreductase activity but retains similar in vitro cytokine activity to Bm-MIF-1 in which these residues are conserved [39].
###end p 8
###begin p 9
###xml 363 365 359 361 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B36" ref-type="bibr">36</xref>
###xml 367 369 363 365 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B41" ref-type="bibr">41</xref>
###xml 369 371 365 367 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B42" ref-type="bibr">42</xref>
###xml 371 373 367 369 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B43" ref-type="bibr">43</xref>
###xml 373 375 369 371 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B44" ref-type="bibr">44</xref>
###xml 639 641 627 629 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 641 643 629 631 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B46" ref-type="bibr">46</xref>
###xml 643 645 631 633 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B47" ref-type="bibr">47</xref>
###xml 645 647 633 635 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B48" ref-type="bibr">48</xref>
###xml 732 734 720 722 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B49" ref-type="bibr">49</xref>
###xml 737 743 725 731 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 909 915 897 903 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 1093 1095 1081 1083 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B46" ref-type="bibr">46</xref>
###xml 1097 1099 1085 1087 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B47" ref-type="bibr">47</xref>
###xml 1101 1103 1089 1091 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B50" ref-type="bibr">50</xref>
###xml 1103 1105 1091 1093 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B51" ref-type="bibr">51</xref>
###xml 1105 1107 1093 1095 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B52" ref-type="bibr">52</xref>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
The synergy between MIF and LPS in the induction of TNF-alpha and IL-6 suggests a role in the classical activation of macrophages by microbial products and proinflammatory cytokines. Yet, over recent years, it has become apparent that in helminth infection, macrophages develop a distinct activation state that is dependent on the Th2 cytokines, IL-4, and IL-13 [36, 41424344]. These "alternatively activated macrophages" (AAMs) are characterized by high-level transcription of arginase type I, the chitinase-like molecule Ym-1 and resistin family member, resistin-like molecule alpha {RELM-alpha; or found in inflammatory zone 1 (Fizz1) [45464748]}, and surface expression of the C-type lectin family member mannose receptor (MR) [49]. Brugia infection of mice has proved a valuable model for the in vivo study of alternative macrophage activation, as large numbers of AAMs arise within 7 days of live adult Brugia transplantation into the peritoneal cavity. These macrophages suppress proliferation of a range of target cells through a contact-dependent mechanism that is dependent on IL-4 [46, 47, 505152].
###end p 9
###begin p 10
###xml 72 78 72 78 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 138 140 138 140 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 224 226 224 226 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 493 495 493 495 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B53" ref-type="bibr">53</xref>
###xml 591 593 591 593 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B54" ref-type="bibr">54</xref>
###xml 647 649 647 649 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
Because of the prominence of these novel macrophages in the response to Brugia and the known activity of MIF for macrophages, we injected Bm-MIF-1 (free of detectable LPS) nine times over 3 weeks into the peritoneal cavity [45]. The infiltrating population of cells was then tested: Although the macrophages were not directly suppressive, they expressed Ym-1, and a threefold rise in eosinophils was also observed, consistent with the description of Ym-1, as an eosinophil chemotactic factor [53] and the recent evidence that AAMs are involved in recruiting eosinophils to peripheral sites [54]. Significantly, such changes were not observed with Bm-MIF-1G mutant recombinant protein nor with LPS at a dose corresponding to that which would have been undetectable in the original MIF-1 preparation.
###end p 10
###begin p 11
###xml 121 123 121 123 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B36" ref-type="bibr">36</xref>
###xml 125 127 125 127 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B55" ref-type="bibr">55</xref>
###xml 129 131 129 131 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B56" ref-type="bibr">56</xref>
These findings have posed a central paradox: Why should parasites that appear masterful at avoiding inflammatory attack [36, 55, 56] secrete molecules that are thought to amplify inflammation? In this study, we questioned whether parasite MIFs do in fact differ functionally from mammalian cytokines and in particular, how in the context of a parasite-induced Th2 response, MIF exposure can promote the generation of AAMs.
###end p 11
###begin title 12
MATERIALS AND METHODS
###end title 12
###begin title 13
Bone marrow-derived macrophages (BMDM)
###end title 13
###begin p 14
###xml 50 54 <span type="species:ncbi:10090">mice</span>
BM cells were taken from femoral bones of C57BL/6 mice and cultured in DMEM supplemented with 20% FCS, 2 mM L-glutamine, 0.25 U/ml penicillin, 100 mug/ml streptomycin, and 20% L929 cell-conditioned medium as a source of M-CSF. At Day 6, culture plates were washed once with PBS at 37degreesC to remove nonadherent cells before detaching adherent macrophages with 3 mM EDTA and 10 mM glucose in PBS. Macrophages were then replated in 24- or 96-well plates at the appropriate concentration and allowed to adhere overnight prior to treatment. Cell preparations were typically >85% F4/80-positive.
###end p 14
###begin title 15
Recombinant MIFs (rMIFs)
###end title 15
###begin p 16
###xml 143 145 143 145 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 393 395 393 395 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 431 447 431 447 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 655 656 649 650 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 659 660 653 654 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 664 665 658 659 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 667 668 661 662 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 148 153 <span type="species:ncbi:10090">Mouse</span>
###xml 431 452 <span type="species:ncbi:511693">Escherichia coli BL21</span>
The pET29 system (Novagen, San Diego, CA, USA) was used for bacterial expression of recombinant 6-His-tagged proteins as described previously [39]. Mouse MIF (mMIF) was produced in the same system, using a coding insert provided generously by Dr. Patrick Skelly (Harvard University, Cambridge, MA, USA). mMIF-G was constructed by altering the codon for Pro-2 within a PCR primer as described [39]. Plasmid DNA was transformed into Escherichia coli BL21(DE3), single colonies were grown at 37degreesC, and recombinant protein expression induced in the presence of 1 mM isopropylthiogalactoside. Recombinant proteins were recovered by sonication in 20 mM Na2HPO4/NaH2PO4, pH 8.0, 0.5 M NaCl, 10 mM imidazole, followed by nickel-chelating affinity chromatography on an AKTAprime system (Amersham Biosciences, Piscataway, NJ, USA). To avoid effects as a result of any endotoxin contamination, recombinant proteins were treated with 20 mug/ml Polymixin B sulfate (Sigma Chemical Co., St. Louis, MO, USA) for 30 min at 37degreesC prior to use in cellular assays.
###end p 16
###begin title 17
In vitro stimulation
###end title 17
###begin p 18
###xml 28 29 28 29 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
For in vitro stimulation, 106 macrophages were incubated with 10 mug/ml each recombinant protein. For some experiments, macrophages were cotreated with IL-4 at different concentrations (0.2-100 ng/ml), as indicated in the text.
###end p 18
###begin title 19
In vivo stimulation
###end title 19
###begin p 20
###xml 25 28 21 24 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
BALB/c mice or IL-4Ralpha-/- mice on the BALB/c background were injected i.p. with 1 mug/ml each recombinant protein, diluted in PBS (pyrogen-free, Sigma Chemical Co., D8537). Control animals were injected with PBS alone. Injections were given twice a week for a total of nine injections.
###end p 20
###begin title 21
Flow cytometry for surface markers
###end title 21
###begin p 22
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 151 154 <span type="species:ncbi:10116">rat</span>
###xml 184 200 <span type="species:ncbi:10032">Armenian hamster</span>
###xml 234 237 <span type="species:ncbi:10116">rat</span>
###xml 337 340 <span type="species:ncbi:10116">rat</span>
Cells were stained at 24 h post-treatment with the following reagents for surface activation markers: MHC-II (clone 2G9, rat IgG2a), CD40 (clone 3/23, rat IgG2a), CD80 (clone 16-10A1, Armenian hamster IgG2Kappa), and CD86 (clone GL1, rat IgG2a; all from Becton Dickinson, San Jose, CA, USA; used at 1:200 dilution) and F4/80 (clone BM8, rat IgG2a, Caltag, South San Francisco, CA, USA). Appropriate isotype controls with same fluorophore were used (Becton Dickinson and Caltag). Cells were analyzed using a FACSCaliber (Becton Dickinson) and FlowJo software, Version 4.5.9.
###end p 22
###begin title 23
Cytokine ELISAs
###end title 23
###begin p 24
Supernatants were collected for cytokine measurement by sandwich ELISA; IL-6 (capture: MP5-20F3; detection: MP5-32C11; top standard: 100 ng/ml), IL-10 (capture: JES5-2A5; detection: SXC-1; top standard: 10 ng/ml), IL-12p40 (capture: C15.6; detection: C17.8; top standard: 200 ng/ml), and IL-12p70 (capture: 9A5; detection: C17.8; top standard: 10 ng/ml) were from PharMingen (San Diego, CA, USA), and TNF-alpha (DY410; top standard: 2 ng/ml) was from R&D Systems (Minneapolis, MN, USA).
###end p 24
###begin title 25
Western blot
###end title 25
###begin p 26
###xml 416 421 <span type="species:ncbi:10090">mouse</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 581 586 <span type="species:ncbi:10090">mouse</span>
Samples were mixed with 4x SDS sample buffer (Invitrogen, Carlsbad, CA, USA) containing 2-ME. Samples were heat-denatured and resolved using precast 10% gradient Bis-Tris-NuPAGE gels (Invitrogen), which were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA, USA), blocked with 5% milk in TBS-0.1% Triton X-100-0.05% Tween 20 (TBSTT), followed by incubation with the appropriate antibodies. Anti-rMIF mouse polyclonal serum, raised by immunization of MIF-deficient mice with recombinant protein, was used at a 1:200 dilution in 5% milk TBSTT, followed by total anti-mouse IgG-HRP conjugate (Dako, Carpineteria, CA, USA) at 1:2000 dilution. ECL substrate (Amersham Biosciences) was used for detection.
###end p 26
###begin title 27
RNA extraction and real-time PCR
###end title 27
###begin p 28
###xml 27 28 27 28 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 641 648 625 632 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="T1" ref-type="table">Table 1</xref>
###xml 741 742 723 724 <sub xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 834 838 815 819 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ym-1</italic>
###xml 186 215 <span type="species:ncbi:11801">Moloney murine leukemia virus</span>
###xml 311 317 <span type="species:ncbi:10090">murine</span>
Following treatment, 1 x 106 macrophages were collected in 1 ml TRIzol (Invitrogen), and RNA extraction was performed following the manufacturer's protocol, transcribing 1 mug RNA using Moloney murine leukemia virus RT (Stratagene, La Jolla, CA, USA). Ym-1, RELMalpha, Arginase-1, inducible NO synthase (iNOS), murine macrophage MR (mMMR), IL-4Ralpha, and IFN-gammaR1 RNA levels were measured by real-time PCR using LightCycler (Roche Molecular Biochemicals, Indianapolis, IN, USA) or Chromo4 (Genetic Research Instrumentation Ltd., UK) real-time PCR machines. beta-Actin or GAPDH were used as reference genes. Primer sequences are given in Table 1. LightCycler PCR amplifications were carried out in 10 mul, containing 1 mul cDNA, 4 mM MgCl2, 0.3 muM primers, and the LightCycler-DNA SYBR Green I mix (Roche Molecular Biochemicals). Ym-1 was amplified using the following conditions: 30 s denaturation at 95degreesC, 5 s annealing of primers at 63degreesC, and 12 s elongation at 72degreesC for 40-60 cycles. The fluorescent DNA-binding dye SYBR Green (Roche Molecular Biochemicals) was monitored after each cycle at 85degreesC. For all other primer pairs, the annealing temperature was 55degreesC, and SYBR Green fluorescence was monitored at 86degreesC. Chromo4 PCR reactions were carried in 10 mul containing 1 mul cDNA, 0.3 muM primers, and SYBR Green Supermix-uracil DNA glycosylase (Invitrogen). The following conditions were used: 15 min hot start at 95degreesC, followed by denaturation at 95degreesC for 20 s, primer annealing at 55degreesC for 20 s, and elongation at 72degreesC 20 s for 50 cycles. The fluorescent DNA-binding dye SYBR Green was monitored after each cycle at 80degreesC. Expression levels were estimated using the absolute quantitation method by comparison with a standard curve generated from a pool of all samples diluted appropriately. Relative expression of the gene of interest was then calculated as the ratio to a housekeeping gene that remained unaltered after treatment. For some experiments, fold-increase over untreated macrophages was calculated.
###end p 28
###begin title 29
Suppression assay
###end title 29
###begin p 30
BMDM were treated with different MIF proteins in the absence or presence of 20 ng/ml IL-4 for 24 h. After this time, supernatants were removed, and EL4 cells were then added at a ratio of 1:10 macrophages, and cells were cocultured for a further 72 h when proliferation was measured by tritiated-thymidine incorporation.
###end p 30
###begin title 31
Anti-MIF mAb production
###end title 31
###begin p 32
###xml 67 69 66 68 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
BALB/c mice were immunized on Day 0 with 100 mug alum-precipitated Bm-MIF-1 and subsequently challenged i.v. with 1 mug protein on Days 28-30. On Day 31, splenocytes were recovered and fused with SP2 myeloma cells. On Day 7 after fusion, cells were screened against recombinant protein by ELISA. Cells from positive wells were cloned by limiting dilution in 96-well plates. Cells were screened and cloned a second time, and selected clones expanded for antibody production. For antibody purification, cells were grown in 500 ml RPMI supplemented with low IgG FCS in disposable bioreactors (VectraCell single-use bioreactor system, BioVectra, Canada). Cells were cultured for 3-4 weeks to allow maximum antibody production. Supernatants were harvested and spun down to remove cells. mAb were purified using a protein-G sepharose column and the AKTAprime system (Amersham Biosciences). Antibody was eluted using 1 M glycine, pH 2.9, into neutralizing buffer (Tris, pH 9). Purified antibodies were dialyzed against PBS, filtered under sterile conditions, and frozen for storage.
###end p 32
###begin title 33
MIF mAb depletion
###end title 33
###begin p 34
###xml 89 95 89 95 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
MIF recombinant proteins were incubated with 10x excess (w/w) 2F11C9 mAb that recognizes Brugia and mouse homologues for 2.5 h at 4degreesC. Immunocomplexes were precipitated using protein-G agarose/sepharose beads (Upstate, Lake Placid, NY, USA), which were spun down, and supernatants were subjected to a second round of immunoprecipitation to ensure complete protein removal.
###end p 34
###begin title 35
Statistical tests
###end title 35
###begin p 36
One-way ANOVA was performed on log-transformed replicate data, and different treatments were compared by Bonferroni post-test using GraphPad Prism 4 software.
###end p 36
###begin title 37
RESULTS
###end title 37
###begin title 38
Stimulation of different macrophage populations by MIFs
###end title 38
###begin p 39
###xml 201 203 201 203 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 211 213 211 213 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 314 321 314 321 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 1A</bold>
###xml 314 321 314 321 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig"><bold>Fig. 1A</bold></xref>
###xml 384 393 384 393 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig">(Fig. 1B)</xref>
###xml 447 449 447 449 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 617 626 617 626 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig">(Fig. 1C)</xref>
###xml 675 677 675 677 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 713 715 713 715 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 728 737 724 733 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig">(Fig. 1D)</xref>
###xml 1396 1399 1392 1395 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
###xml 80 86 <span type="species:ncbi:10090">murine</span>
###xml 696 701 <span type="species:ncbi:9606">human</span>
###xml 1227 1232 <span type="species:ncbi:10090">mouse</span>
To compare the functions of mouse and helminth MIF homologues, we first treated murine BMDM with rMIF proteins for 24 h and assayed cytokine release as a measure of activation. The three MIF proteins (Bm-MIF-1, Bm-MIF-2, and mMIF) exerted similar effects in this regard, with IL-12p40 release at all doses tested (Fig. 1A) and additional IL-10 production at higher MIF concentrations (Fig. 1B). It was noted that the tautomerase-deficient mutants Bm-MIF-1G and -2G acted with similar potency to the wild-type proteins, and the mutant mMIF-G was greatly attenuated in effect. All MIF products tested also induced IL-6 (Fig. 1C) production and as has been noted previously for Bm-MIF-1 and -2 with human monocytes [39], TNF-alpha (Fig. 1D). Neither IL-12p70 nor IL-23 was produced at any detectable level (data not shown). Quantitatively, levels of IL-12p40, IL-10, and IL-6 released were of a similar magnitude to, but lower than, those elicited by LPS stimulation and resistant to Polymixin B inhibition. A similar pattern of cytokine release was observed with thioglycollate-elicited peritoneal and purified splenic macrophage populations (data not shown). Activation was also assessed by flow cytometry, and although neither mouse nor parasite MIF altered expression of the costimulatory molecules CD40, CD80, or CD86, a reduction in MHC-II expression was observed after treatment with mMIF or Bm-MIF-2 (data not shown). MIF-stimulated macrophages were also tested for production of NO by assay of culture supernatants by the Greiss reaction, but levels were not found to be significantly above background amounts (data not shown).
###end p 39
###begin title 40
MIF depletion from the recombinant preparations abolishes cytokine production
###end title 40
###begin p 41
###xml 621 630 615 624 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig">(Fig. 1E)</xref>
###xml 641 650 635 644 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F1" ref-type="fig">(Fig. 1F)</xref>
To verify that macrophage stimulation was specific for the MIF proteins, we depleted MIF from each preparation with a mAb (2F11C9) specific for, and cross-reactive between, mammalian and parasite MIF proteins (see Materials and Methods). Aliquots were subjected to two rounds of incubation with an excess of antibody for 2 h at 4degreesC, following which, immunocomplexes were removed on protein-G sepharose beads. SDS-PAGE analysis confirmed that all detectable MIF protein had been removed by this procedure, and samples no longer containing MIF were unable to stimulate macrophages, as judged by the abolition of IL-6 (Fig. 1E) and IL-10 (Fig. 1F) responses.
###end p 41
###begin title 42
Filarial MIF homologues do not induce production of endogenous mMIF
###end title 42
###begin p 43
###xml 383 389 383 389 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 2</bold>
###xml 383 389 383 389 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F2" ref-type="fig"><bold>Fig. 2</bold></xref>
###xml 507 513 <span type="species:ncbi:10090">murine</span>
As exposure of macrophages to MIF homologues from parasites might elict secretion of endogenous mMIF, thereby acting indirectly in these experiments, we probed culture supernatants from stimulated macrophages with an antibody specific for mMIF. We noted a constitutive level of MIF secretion from unstimulated cells, which was not increased in the presence of parasite MIF proteins (Fig. 2), indicating that the effects observed can be attributed directly to parasite MIF homologues rather than through the murine cytokine.
###end p 43
###begin title 44
MIF homologues enhance alternative activation of macrophages induced by IL-4
###end title 44
###begin p 45
###xml 44 47 44 47 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 135 137 135 137 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 328 330 324 326 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 330 332 326 328 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B46" ref-type="bibr">46</xref>
###xml 332 334 328 330 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B47" ref-type="bibr">47</xref>
###xml 334 336 330 332 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B48" ref-type="bibr">48</xref>
###xml 349 351 345 347 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B57" ref-type="bibr">57</xref>
###xml 769 771 761 763 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B47" ref-type="bibr">47</xref>
###xml 773 775 765 767 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B58" ref-type="bibr">58</xref>
###xml 777 779 769 771 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B59" ref-type="bibr">59</xref>
We have described previously the ability of Bm-MIF-1, when administered in vivo, to promote the alternative activation of macrophages [45]. We first attempted to reproduce this effect in vitro by incubating MIF homologues with BMDM. As markers for alternative activation, we measured expression of Ym-1, RELM-alpha, Arginase-1 [45464748], and mMMR [57] by real-time PCR. In these experiments, however, no up-regulation of alternative activation marker genes was detected when incubating macrophages with increasing concentration of parasite MIF (data not shown), raising the question of whether other factors present in vivo might be required in our in vitro system. As macrophage expression of Ym-1, RELM-alpha, and Arginase-1 is induced by IL-4 in vivo and in vitro [47, 58, 59], we tested the response of macrophages cultured with MIF in the presence of increasing concentrations of IL-4. After overnight treatment, cells were collected in TRIzol for RNA extraction, and expression levels of Ym-1, RELM-alpha, and Arginase-1 were measured by real-time PCR. In addition, we assayed iNOS as a marker of classical macrophage activation. beta-Actin and GAPDH were used as reference genes and showed equivalent results.
###end p 45
###begin p 46
###xml 0 11 0 11 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Figure 3A&#8211;C</bold>
###xml 0 11 0 11 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F3" ref-type="fig"><bold>Figure 3A&#8211;C</bold></xref>
###xml 365 368 364 367 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 586 588 585 587 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 599 601 598 600 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 785 794 784 793 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F3" ref-type="fig">(Fig. 3D)</xref>
###xml 906 913 901 908 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F3" ref-type="fig">Fig. 3B</xref>
Figure 3A-C, shows that although MIF homologues alone were unable to induce expression of alternative activation markers, a marked synergy occurred in the presence of IL-4, reaching an optimal level at 10 mug/ml rMIF with 20 ng/ml IL-4. Interestingly the synergistic effect of the different MIF homologues differed between mammalian and filarial proteins. Although Bm-MIF-1 and -2 preferentially enhanced Ym-1 expression (6.5- and 14.8-fold over 20 ng/ml IL-4), mMIF with IL-4 induced higher Arginase-1 levels (17.2-fold increase over 20 ng/ml IL-4 compared with 6.1 and 7.4 induced by Bm-MIF-1 and Bm-MIF-2, respectively). Perhaps most strikingly, mMIF alone induced iNOS in macrophages, which in the presence of IL-4, was abolished in favor of the production of arginase transcripts (Fig. 3D). Only RELM-alpha showed no clear synergies with MIF, as this was induced strongly by IL-4 alone (black line in Fig. 3B).
###end p 46
###begin title 47
MIF homologues induce up-regulation of IL-4Ralpha
###end title 47
###begin p 48
###xml 62 64 58 60 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B42" ref-type="bibr">42</xref>
###xml 66 68 62 64 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B43" ref-type="bibr">43</xref>
###xml 443 450 426 433 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 4A</bold>
###xml 443 450 426 433 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F4" ref-type="fig"><bold>Fig. 4A</bold></xref>
###xml 685 694 664 673 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F4" ref-type="fig">(Fig. 4A)</xref>
###xml 875 884 850 859 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F4" ref-type="fig">(Fig. 4B)</xref>
###xml 900 909 875 884 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F4" ref-type="fig">(Fig. 4C)</xref>
###xml 983 985 958 960 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B49" ref-type="bibr">49</xref>
Macrophage alternative activation is dependent on IL-4Ralpha [42, 43]. To elucidate whether the mechanism by which MIF enhances IL-4 activation involves IL-4Ralpha up-regulation, BMDM were cotreated with 20 ng/ml IL-4 and 10 mug/ml MIF and IL-4Ralpha expression measured by RT-PCR. All three MIF homologues induced IL-4Ralpha expression in the absence of IL-4, although in the case of mMIF, the change did not attain statistical significance (Fig. 4A). Importantly, treament of macrophages with IL-4 alone did not raise IL-4Ralpha mRNA levels, and it required the combination of both ligands to achieve a substantial increase in expression levels; this was true for all MIF homologues (Fig. 4A). IL-4Ralpha induction was observed in the presence of wild-type and tautomerase-deficient proteins. The synergy between MIF and IL-4 was again evident in the induction of arginase (Fig. 4B) and of the FMR (Fig. 4C), which is an additional marker of alternative activation of macrophages [49]. Arginase and MR levels were elevated in the presence of IL-4 alone but were greatly enhanced on addition of any of the MIF proteins tested.
###end p 48
###begin p 49
###xml 158 165 150 157 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 5A</bold>
###xml 158 165 150 157 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F5" ref-type="fig"><bold>Fig. 5A</bold></xref>
###xml 476 491 468 483 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F5" ref-type="fig">Fig. 5, B and C</xref>
###xml 566 575 558 567 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F5" ref-type="fig">(Fig. 5D)</xref>
In contrast to the strongly synergistic enhancement of IL-4Ralpha in macrophages by MIF proteins, similarly treated cells did not up-regulate the IFN-gammaR (Fig. 5A). Indeed, a small reduction in transcript levels appears to accompany MIF exposure (although this did not reach statistical significance), and IL-4 itself was necessary and sufficient to suppress transcript levels. IL-4 was also found to inhibit the ability of MIF to induce proinflammatory IL-6 and IL-12p40 (Fig. 5, B and C), while having no effect on the macrophage IL-10 response to MIF proteins (Fig. 5D). As IL-4 alone cannot stimulate IL-10 production, the combination of MIF stimulation and selective inhibition by IL-4 results in a strongly polarized, counter-inflammatory outcome.
###end p 49
###begin title 50
MIF homologues synergize with IL-4 to suppress EL4 proliferation
###end title 50
###begin p 51
###xml 132 134 132 134 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B44" ref-type="bibr">44</xref>
###xml 136 138 136 138 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B52" ref-type="bibr">52</xref>
###xml 140 142 140 142 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B60" ref-type="bibr">60</xref>
###xml 144 146 144 146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B61" ref-type="bibr">61</xref>
###xml 512 519 512 519 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 6A</bold>
###xml 512 519 512 519 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F6" ref-type="fig"><bold>Fig. 6A</bold></xref>
###xml 968 977 968 977 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F6" ref-type="fig">(Fig. 6B)</xref>
###xml 1042 1044 1042 1044 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1052 1054 1052 1054 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1202 1211 1202 1211 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F6" ref-type="fig">(Fig. 6C)</xref>
A notable feature of AAMs is their ability to suppress T cell proliferation, an important characteristic during helminth infection [44, 52, 60, 61]. To test whether MIF homologues are involved in the induction of this key functional characteristic, BMDM were treated as before with MIF in the presence or absence of 20 ng/ml IL-4 overnight. After this time, EL4 cells were added to cultures at a 1:10 ratio. Cells were cocultured for 72 h, following which, proliferation was measured by thymidine incorporation (Fig. 6A). Macrophages that had been treated with any of the MIF proteins alone exerted a small reduction in the proliferation of EL4 cells in vitro, which did not reach statistical significance. Similarly, IL-4-treated macrophages were able to effect only a small reduction in EL4 cell-proliferative activity. However, in the presence of exogenous IL-4, MIF homologues induced macrophages to be strongly suppressive, effectively blocking EL4 proliferation (Fig. 6B). Up to 75% suppression was observed from macrophages exposed to Bm-MIF-1, Bm-MIF-2, or mMIF. Suppression was also observed, albeit at a more modest level, when macrophages were treated with tautomerase-deficient MIF mutants (Fig. 6C).
###end p 51
###begin title 52
###xml 0 6 0 6 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
Brugia MIF but not mMIF induces alternative activation in vivo
###end title 52
###begin p 53
###xml 58 61 58 61 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 75 77 75 77 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 219 221 219 221 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 574 581 574 581 <bold xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fig. 7A</bold>
###xml 574 581 574 581 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F7" ref-type="fig"><bold>Fig. 7A</bold></xref>
###xml 609 618 605 614 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F7" ref-type="fig">(Fig. 7B)</xref>
###xml 634 643 630 639 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F7" ref-type="fig">(Fig. 7C)</xref>
###xml 647 650 643 646 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 1025 1027 1021 1023 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1091 1100 1087 1096 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="F7" ref-type="fig">(Fig. 7D)</xref>
###xml 1166 1168 1162 1164 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B53" ref-type="bibr">53</xref>
###xml 1170 1172 1166 1168 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B62" ref-type="bibr">62</xref>
###xml 1178 1180 1174 1176 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1579 1582 1567 1570 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 1518 1522 <span type="species:ncbi:10090">mice</span>
We had demonstrated previously that repeated injection of Bm-MIF-1 but not Bm-MIF-1G induced macrophage and eosinophil recruitment to the peritoneal cavity, with induction of Ym-1 as a marker of alternative activation [45]. We chose to repeat and extend these in vivo experiments to determine whether the activity of mMIF was comparable with that of parasite MIF. BALB/c mice were injected i.p. with recombinant protein nine times over a 3-week period. As described previously, MIF-1 but not MIF-1G induced Ym-1 expression in macrophages recruited to the peritoneal cavity (Fig. 7A). Expression of RELM-alpha (Fig. 7B) and Arginase-1 (Fig. 7C) by Bm-MIF-1-elicited macrophages further supported the conclusion that these cells were alternatively activated. Interestingly, mMIF showed a tendency to induce a similar expression profile, although not statistically significant, in a pattern consistent with the in vitro data, in which mMIF-1 was able to promote Ym-1 and Arginase-1 expression in the presence of IL-4. Moreover, Bm-MIF-1 and mMIF injections stimulated a peritoneal eosinophilia (Fig. 7D), which has previously been associated with the presence of Ym-1 [53, 62]. As Bm-MIF-1 induces a more robust expression of key macrophage genes in vivo than does mMIF, we hypothesize that the parasite proteins also stimulate an adaptive immune response in vivo, including the enhancement of IL-4, which amplifies the alternative activation pathway. Consistent with this proposition, we also noted IL-4Ralpha-deficient mice are unable to produce Ym-1 or RELM-alpha in response to Bm-MIF-1 challenge in vivo (data not shown).
###end p 53
###begin title 54
DISCUSSION
###end title 54
###begin p 55
###xml 89 91 89 91 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B30" ref-type="bibr">30</xref>
###xml 93 95 93 95 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B63" ref-type="bibr">63</xref>
###xml 97 99 97 99 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B64" ref-type="bibr">64</xref>
###xml 241 262 241 262 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 264 266 264 266 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B65" ref-type="bibr">65</xref>
###xml 268 270 268 270 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B66" ref-type="bibr">66</xref>
###xml 276 284 276 284 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">L. major</italic>
###xml 286 288 286 288 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B67" ref-type="bibr">67</xref>
###xml 338 344 338 344 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 345 347 345 347 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B38" ref-type="bibr">38</xref>
###xml 349 351 349 351 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 357 377 357 377 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Trichinella spiralis</italic>
###xml 379 381 379 381 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B68" ref-type="bibr">68</xref>
###xml 637 643 637 643 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 213 216 <span type="species:ncbi:9606">man</span>
###xml 241 262 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 276 284 <span type="species:ncbi:5664">L. major</span>
###xml 357 377 <span type="species:ncbi:6334">Trichinella spiralis</span>
###xml 433 436 <span type="species:ncbi:9606">man</span>
MIF is an important, if incompletely understood, cytokine with deep, evolutionary roots [30, 63, 64]. In recent years, expression of MIF homologues has been reported in a range of parasitic organisms infective to man, including the protozoa Plasmodium falciparum [65, 66] and L. major [67], and among the helminth worms, in the nematodes Brugia[38, 39] and Trichinella spiralis [68]. In characterizing MIF from helminth parasites of man, the question arises of whether parasite molecules mimic or counteract the host cytokine and if the study of parasite MIF may reveal a hitherto unknown facet of the mammalian molecule. In now linking Brugia MIF with the alternative activation of macrophages, we have also shown that mammalian MIF can, in the context of a type-2 environment, promote a similar phenotype in host macrophage populations.
###end p 55
###begin p 56
###xml 32 38 32 38 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 110 112 110 112 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B38" ref-type="bibr">38</xref>
###xml 114 116 114 116 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 152 155 152 155 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 227 229 227 229 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B38" ref-type="bibr">38</xref>
###xml 240 242 240 242 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 299 301 299 301 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B39" ref-type="bibr">39</xref>
###xml 339 341 339 341 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 474 477 474 477 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm-</italic>
###xml 540 542 540 542 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 783 789 783 789 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 208 213 <span type="species:ncbi:9606">human</span>
MIFs from the filarial nematode Brugia were first characterized by their homology with the mammalian protein [38, 39]. Functional studies revealed that Bm-MIF-1 has the ability to inhibit random migration of human macrophages [38] and that Bm-MIF-1 and -2 induce cytokine production by these cells [39]. In addition, the potential role of Bm-MIF-1 in alternative activation of macrophages during filarial infection was suggested by the observation that in vivo injection of Bm-MIF-1 induced a population of macrophages that expressed Ym-1 [45]. These different observations lead us to hypothesize that although mammalian MIF is a potent proinflammatory factor, filarial homologues will activate macrophages to an alternative phenotype that contributes to counter-inflammation during Brugia infection.
###end p 56
###begin p 57
###xml 127 133 127 133 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
We first analyzed the direct effect of each parasite MIF homologue on macrophages in comparison with the host protein. Neither Brugia nor mMIF significantly altered macrophage surface phenotype but were able to stimulate cytokine production by in vitro-differentiated and ex vivo-purified macrophage populations. We then demonstrated a new function for MIF in synergizing with IL-4 for the induction of AAM function and associated gene expression. In addition, the synergy we report between MIF and IL-4 appears at several levels. For example, by increasing IL-4Ralpha expression, MIF can prime macrophages to respond to Th2 conditions, and the ability of MIF to elicit proinflammatory cytokines is ablated in the presence of IL-4.
###end p 57
###begin p 58
###xml 144 146 144 146 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B69" ref-type="bibr">69</xref>
###xml 146 148 146 148 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B70" ref-type="bibr">70</xref>
###xml 148 150 148 150 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B71" ref-type="bibr">71</xref>
###xml 319 321 315 317 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B47" ref-type="bibr">47</xref>
###xml 339 341 335 337 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B43" ref-type="bibr">43</xref>
###xml 343 345 339 341 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B58" ref-type="bibr">58</xref>
###xml 435 437 431 433 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B52" ref-type="bibr">52</xref>
###xml 581 583 577 579 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B72" ref-type="bibr">72</xref>
###xml 624 630 620 626 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 659 661 655 657 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
Helminth parasites, in common with allergenic stimuli, are powerful initiators of the type-2 response with prominent IL-4 and IL-13 production [697071]. These cytokines act through the IL-4Ralpha pathway and STAT-6 phosphorylation to induce an alternatively activated phenotype characterized by the production of Ym-1 [47] and Arginase-1 [43, 58], expression of surface MRs, and the elaboration of functional cell-suppressor capacity [52]. Our recent work has demonstrated the importance of IL-4R signaling in the innate induction of Ym-1 and other alternative activation markers [72]. The present work now suggests that in Brugiainfection, parasite-released Bm-MIF may be the first stimulus for macrophages to begin alternative differentiation but that host IL-4 is necessary for this process to complete.
###end p 58
###begin p 59
###xml 17 23 17 23 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
Although the two Brugia homologues, MIF-1 and -2, are more potent than mMIF at inducing Ym-1 and RELM-alpha in vitro and at driving alternative macrophage activation in vivo, the homologues are broadly equivalent in stimulation of in vitro cytokine production from macrophages. Moreover, mutants lacking tautomerase enzyme activity are able to induce cytokines and alternative activation in vitro. However, these mutants are inactive in vivo, indicating a lower potency in a system that we have determined requires nine injections to achieve a significant effect (W. F. Gregory, unpublished observations). As MIF-2 lacks the conserved oxidoreductase site with three conserved cysteine residues in identical positions (57, 60, and 81), this activity is evidently not required for immunological effects. Hence, the induction of AAM-related transcripts is likely to be independent of ERK1/2 phosphorylation events, as discussed below, or the production of inflammatory cytokines.
###end p 59
###begin p 60
###xml 190 192 190 192 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B32" ref-type="bibr">32</xref>
###xml 271 273 271 273 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B31" ref-type="bibr">31</xref>
###xml 733 752 733 752 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Ancylostoma caninum</italic>
###xml 791 793 791 793 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B40" ref-type="bibr">40</xref>
###xml 829 835 829 835 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia</italic>
###xml 733 752 <span type="species:ncbi:29170">Ancylostoma caninum</span>
A major unresolved issue is how parasite MIF molecules may signal to host macrophages. It is known that mMIF activates the MAPK pathway, particularly through ERK1/2 and p38 phosphorylation [32], in a manner that can be mediated through CD74 and is tautomerase-dependent [31]. However, our studies to date do not indicate that an identical signaling pathway is in play with respect to the parasite MIFs, which retain activity in the tautomerase-deficient mutants, are markedly less potent in activating MAPK phosphorylation (unpublished results), and can stimulate CD74-deficient macrophages (L. Prieto-Lafuente and Elizabeth Bikoff, unpublished data). Interestingly, it has been shown recently that a MIF homologue from the hookworm Ancylostoma caninum is able to bind to the CD74 receptor [40], and similar experiments with the Brugia molecules would advance our knowledge in this area.
###end p 60
###begin p 61
###xml 206 208 206 208 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B30" ref-type="bibr">30</xref>
###xml 210 212 210 212 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B35" ref-type="bibr">35</xref>
###xml 353 355 353 355 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B22" ref-type="bibr">22</xref>
###xml 357 359 357 359 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B24" ref-type="bibr">24</xref>
###xml 372 374 372 374 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B21" ref-type="bibr">21</xref>
###xml 397 399 397 399 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B23" ref-type="bibr">23</xref>
The concept that MIF can exert anti-inflammatory effects is certainly not new, as inactivation of Jab1 at the intracellular level has been predicted to have a down-modulatory impact on the immune response [30, 35]. At the systemic level, some striking examples of MIF acting to suppress immunity have emerged from tumor studies, in which neuroblastoma [22, 24], melanoma [21], and ovarian cancer [23] cells have each been found to overexpress MIF, with suppressive consequences for NK and T cell functions. Mechanistic parallels between immune evasion by tumors and parasites are rarely explored, and it is possible that further research into MIF in this regard would be well worthwhile.
###end p 61
###begin p 62
###xml 259 261 259 261 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 326 328 326 328 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B45" ref-type="bibr">45</xref>
###xml 352 354 352 354 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1289 1291 1281 1283 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B12" ref-type="bibr">12</xref>
###xml 1293 1295 1285 1287 <xref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" rid="B13" ref-type="bibr">13</xref>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
In conclusion, our data support the hypothesis that filarial MIF homologues promote alternative activation of macrophages and further argue that mammalian MIF can exert the same effect under similar circumstances of a strong Th2 environment. The link between Bm-MIF-1 and alternative activation has been indicated previously [45], and we now show that Bm-MIF-2 and mouse-MIF can, in the presence of IL-4, induce macrophage expression of alternative activation markers in vivo or in vitro. Critically, MIF showed marked synergy with IL-4, enhancing the expression of alternative activation markers induced by IL-4 alone, as well as synergizing to render macrophages suppressive. Moreover, MIF alone induced IL-4Ralpha expression, and IL-4Ralpha levels were strongly up-regulated when IL-4 was present in the media. Taken together, these data suggest that MIF is not a unidirectional mediator that always promotes classical, type-1 inflammation but acts on macrophages according to the prevailing cytokine environment. In a setting in which innate inflammatory mediators are induced, such as septic shock, MIF is certainly a powerful amplifier of inflammation. Our results suggest that in other contexts-in the Th2 milieu of helminth infection, as well as, evidently, allergic inflammation [12, 13]-MIF may accelerate the development of type-2 reactivity, including AAMs and eosinophilia.
###end p 62
###begin p 63
We thank the Wellcome Trust for grant support and Prof. Andy Waters and Drs. Joanne Thompson and Kevin Augustijn for discussions and critical comments. We thank Dr. James Hewitson for preparation of essential materials and Drs. Patrick Skelly and Chuck Shoemaker for the generous gift of mMIF cDNA.
###end p 63
###begin article-title 64
Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
###end article-title 64
###begin article-title 65
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction
###end article-title 65
###begin article-title 66
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
###end article-title 66
###begin article-title 67
Macrophage migration inhibitory factor: a regulator of innate immunity
###end article-title 67
###begin article-title 68
The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma
###end article-title 69
###begin article-title 70
MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia
###end article-title 70
###begin article-title 71
Role of macrophage migration inhibitory factor in the regulation of the immune response
###end article-title 71
###begin article-title 72
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease
###end article-title 72
###begin article-title 73
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
###end article-title 73
###begin article-title 74
Development of chronic colitis is dependent on the cytokine MIF
###end article-title 74
###begin article-title 75
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses
###end article-title 75
###begin article-title 76
Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation
###end article-title 76
###begin article-title 77
MIF regulates innate immune responses through modulation of Toll-like receptor 4
###end article-title 77
###begin article-title 78
###xml 86 108 86 108 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Salmonella typhimurium</italic>
###xml 86 108 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium
###end article-title 78
###begin article-title 79
###xml 77 93 77 93 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Leishmania major</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 77 93 <span type="species:ncbi:5664">Leishmania major</span>
Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection
###end article-title 79
###begin article-title 80
###xml 115 132 115 132 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Taenia crassiceps</italic>
###xml 115 132 <span type="species:ncbi:6207">Taenia crassiceps</span>
Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps
###end article-title 80
###begin article-title 81
###xml 83 100 83 100 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Taenia crassiceps</italic>
###xml 83 100 <span type="species:ncbi:6207">Taenia crassiceps</span>
A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps
###end article-title 81
###begin article-title 82
Mechanisms and effectors of MIF-dependent promotion of tumorigenesis
###end article-title 82
###begin article-title 83
Role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells
###end article-title 84
###begin article-title 85
Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation
###end article-title 85
###begin article-title 86
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D
###end article-title 86
###begin article-title 87
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo
###end article-title 87
###begin article-title 88
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor
###end article-title 88
###begin article-title 89
Regulated secretion of macrophage migration inhibitory factor is mediated by a non-classical pathway involving an ABC transporter
###end article-title 89
###begin article-title 90
The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction
###end article-title 90
###begin article-title 91
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase
###end article-title 91
###begin article-title 92
MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response
###end article-title 92
###begin article-title 93
A most interesting factor
###end article-title 93
###begin article-title 94
MIF signal transduction initiated by binding to CD74
###end article-title 94
###begin article-title 95
Rapid and transient activation of the ERK MAPK signaling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity
###end article-title 95
###begin article-title 96
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex
###end article-title 96
###begin article-title 97
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
###end article-title 97
###begin article-title 98
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
###end article-title 98
###begin article-title 99
Helminth parasites: masters of regulation
###end article-title 99
###begin article-title 100
Orthologs of macrophage migration inhibitory factor from parasitic nematodes
###end article-title 100
###begin article-title 101
###xml 55 60 <span type="species:ncbi:9606">human</span>
Filarial nematode parasites secrete a homologue of the human cytokine macrophage migration inhibitory factor
###end article-title 101
###begin article-title 102
###xml 14 19 <span type="species:ncbi:9606">human</span>
Homologues of human macrophage migration inhibitory factor from a parasitic nematode: gene cloning, protein activity and crystal structure
###end article-title 102
###begin article-title 103
###xml 135 140 <span type="species:ncbi:9606">human</span>
Structural and functional characterization of a secreted hookworm macrophage migration inhibitory factor (MIF) that interacts with the human MIF receptor CD74
###end article-title 103
###begin article-title 104
Divergent roles for macrophages in lymphatic filariasis
###end article-title 104
###begin article-title 105
###xml 153 172 153 172 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Schistosoma mansoni</italic>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 153 172 <span type="species:ncbi:6183">Schistosoma mansoni</span>
IL-4 receptor signaling is required for mannose receptor expression by macrophages recruited to granulomata but not resident cells in mice infected with Schistosoma mansoni
###end article-title 105
###begin article-title 106
Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology
###end article-title 106
###begin article-title 107
Alternatively activated macrophages in helminth infections
###end article-title 107
###begin article-title 108
###xml 2 15 2 15 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia malayi</italic>
###xml 2 15 <span type="species:ncbi:6279">Brugia malayi</span>
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection
###end article-title 108
###begin article-title 109
IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype
###end article-title 109
###begin article-title 110
Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro
###end article-title 110
###begin article-title 111
Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells
###end article-title 111
###begin article-title 112
Macrophage receptors and immune recognition
###end article-title 112
###begin article-title 113
###xml 68 81 68 81 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Brugia malayi</italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 68 81 <span type="species:ncbi:6279">Brugia malayi</span>
Antigen presenting cells from mice harboring the filarial nematode, Brugia malayi, prevent cellular proliferaton but not cytokine production
###end article-title 113
###begin article-title 114
Requirement for in vivo production of IL-4, but not IL-10, in the induction of proliferative suppression by filarial parasites
###end article-title 114
###begin article-title 115
Alternatively activated macrophages induced by nematode infection inhibit proliferation via cell to cell contact
###end article-title 115
###begin article-title 116
Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein
###end article-title 116
###begin article-title 117
Eosinophils develop in distinct stages and are recruited to peripheral sites by alternatively activated macrophages
###end article-title 117
###begin article-title 118
Helminths and harmony
###end article-title 118
###begin article-title 119
Have gastrointestinal nematodes outwitted the immune system?
###end article-title 119
###begin article-title 120
Alternative activation of macrophages
###end article-title 120
###begin article-title 121
Differential regulation of nitric oxide synthase-2 and Arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism
###end article-title 121
###begin article-title 122
Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages
###end article-title 122
###begin article-title 123
Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability
###end article-title 123
###begin article-title 124
###xml 35 52 35 52 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Fasciola hepatica</italic>
###xml 35 52 <span type="species:ncbi:6192">Fasciola hepatica</span>
Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages
###end article-title 124
###begin article-title 125
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice
###end article-title 125
###begin article-title 126
###xml 88 110 88 110 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis elegans</italic>
###xml 88 110 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
Macrophage migration inhibitory factor (MIF) transcription is significantly elevated in Caenorhabditis elegans dauer larvae
###end article-title 126
###begin article-title 127
Macrophage migration inhibitory factor (MIF) of jawed and jawless fishes: implications for its evolutionary origin
###end article-title 127
###begin article-title 128
###xml 35 56 35 56 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 61 71 61 71 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P. berghei</italic>
###xml 35 56 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 61 71 <span type="species:ncbi:5821">P. berghei</span>
Functional characterization of the Plasmodium falciparum and P. berghei homologues of macrophage migration inhibitory factor
###end article-title 128
###begin article-title 129
###xml 22 43 22 43 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Plasmodium falciparum</italic>
###xml 22 43 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue
###end article-title 129
###begin article-title 130
###xml 2 12 2 12 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Leishmania</italic>
A Leishmania ortholog of macrophage migration inhibitory factor modulates host macrophage responses
###end article-title 130
###begin article-title 131
###xml 65 85 65 85 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Trichinella spiralis</italic>
###xml 65 85 <span type="species:ncbi:6334">Trichinella spiralis</span>
Macrophage migration inhibitory factor of the parasitic nematode Trichinella spiralis
###end article-title 131
###begin article-title 132
###xml 70 89 70 89 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Schistosoma mansoni</italic>
###xml 70 89 <span type="species:ncbi:6183">Schistosoma mansoni</span>
Th2 response polarization during infection with the helminth parasite Schistosoma mansoni
###end article-title 132
###begin article-title 133
Infections and allergy-helminths, hygiene and host immune regulation
###end article-title 133
###begin article-title 134
Mapping immune response profiles: the emerging scenario from helminth immunology
###end article-title 134
###begin article-title 135
Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection
###end article-title 135
###begin p 136
Primers Used for Real-Time PCR
###end p 136
###begin p 137
for, Forward; rev, reverse.
###end p 137
###begin p 138
###xml 561 563 557 559 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 629 631 621 623 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 1135 1136 1119 1120 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
In vitro cytokine release from MIF-stimulated macrophages. (A-C) Seven-day C57BL/6 BMDM were treated with 1, 5, or 10 mug/ml rMIF proteins overnight, and supernatants were harvested for IL-12p40 (A), IL-10 (B), and IL-6 (C) analysis by ELISA. "G" proteins represent P2G site-directed mutants, in which tautomerase enzyme activity has been ablated by replacement of Pro-2 with Gly. In direct comparisons of macrophages stimulated with 100 ng/ml LPS, MIF proteins elicited similar or lower responses (e.g., IL-12p40, LPS stimulation 9.0+/-2.9 ng/ml and 10 mug/ml Bm-MIF-1 7.7+/-3.1 ng/ml; IL-6, LPS stimulation 8.8+/-3.0 ng/ml and Bm-MIF-1 4.3+/-1.1 ng/ml), and responses to MIF were not inhibited by Polymixin B treatment, which ablated responses to LPS completely. (D) TNF-alpha cytokine release from BMDM stimulated with 10 mug/ml rMIF proteins, which (E and F) were removed from the indicated preparations with a specific mAb (clone 2F11C9), and BMDM were treated with 10 mug/ml rMIF or the equivalent volume of the depleted fraction. IL-6 (E) and IL-10 (F) release was measured after 24 h. Data were analyzed by one-way ANOVA. ***, P < 0.001, compared with PBS treatment.
###end p 138
###begin p 139
Macrophages were treated with the indicated proteins and supernatants collected after 24 h and separated on SDS-PAGE for Western blot analysis probed with polyclonal antibody to mMIF, which does not cross-react with parasite MIF (upper panel) or control normal serum (lower panel). Note that the strong band in mMIF-treated supernatant is a result of residual recombinant protein in the supernatant reacting with the antibody.
###end p 139
###begin p 140
MIF homologues synergize with IL-4 to induce gene expression characteristic of AAMs. BMDM were treated with 10 mug/ml rMIF in the presence of increasing concentrations of IL-4 for 24 h, following which, cells were harvested in TRIzol for RNA extraction and analysis by real-time PCR as described in Materials and Methods. Graphs represent expression levels of (A) Ym-1, (B) RELM-alpha (also known as Fizz-1), (C) Arginase-1, and (D) iNOS. Data are expressed as fold-increase over untreated macrophages and are pooled from two independent experiments with similar results.
###end p 140
###begin p 141
###xml 498 499 493 494 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 512 513 507 508 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 527 528 522 523 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 569 570 564 565 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 583 584 578 579 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 598 599 593 594 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
MIF homologues up-regulate expression of IL-4R and MR. BMDM were treated with 10 mug/ml rMIF in the presence or absence of 20 ng/ml IL-4 for 24 h, following which, cells were harvested and analyzed as above for expression levels of (A) IL-4Ralpha, (B) arginase, and (C) MR. Expression levels are calculated in arbitrary units relative to a housekeeping gene control (GAPDH). Statistical significances were assessed by one-way ANOVA of transformed (log) data, including the Bonferroni post-test. *, P < 0.05; **, P < 0.01; ***, P < 0.001, compared with medium alone; +, P < 0.05; ++, P < 0.01; +++, P < 0.001, compared with corresponding group without IL-4.
###end p 141
###begin p 142
###xml 512 513 506 507 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 526 527 520 521 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 540 541 534 535 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Counter-inflammatory effects of MIF and IL-4 combinations. (A) Macrophages were incubated for 24 h with 10 mug/ml of the indicated proteins in the absence or presence of IL-4 and levels of expression of IFN-gammaR measured by real-time PCR relative to a control gene. AU, Arbitrary units. (B-D) BMDM were treated with 10 mug/ml rMIF in the presence or absence of 20 ng/ml IL-4 for 24 h, following which, supernatants were tested for IL-6 (B), IL-12p40 (C), and IL-10 (D). Data were analyzed by one-way ANOVA. *, P < 0.05; **, P< 0.01; ***, P< 0.001, compared with treatment with PBS.
###end p 142
###begin p 143
###xml 124 125 124 125 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 248 249 247 248 <sup xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 723 724 722 723 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 737 738 736 737 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 752 753 751 752 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Suppression of proliferation by AAMs treated with MIF and IL-4. (A) Schematic of experimental assay; wells containing 1 x 105 BMDM were treated (for 24 h) with 10 mug/ml each rMIF in the presence or absence of 20 ng/ml IL-4. After this time, 1 x 104 EL4 cells were added to each well. Cells were cocultured for a further 72 h, following which, proliferation was measured by thymidine incorporation. (B and C) Proliferative responses of EL4 cells cocultured with macrophages exposed to MIF proteins with or without exogenous IL-4. (B) Wild-type MIF proteins; (C) MIF-G mutants. Statistical significances were assessed by one-way ANOVA of transformed (log) data, including the Bonferroni post-test. n.s., Not significant. *, P < 0.05; **, P < 0.01; ***, P < 0.001, compared with medium (PBS) alone.
###end p 143
###begin p 144
###xml 54 56 54 56 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">Bm</italic>
###xml 767 768 760 761 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 782 783 775 776 <italic xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
In vivo induction of AAM products and eosinophilia by Bm-MIF-1. (A) Ym-1 transcript levels measured by RT-PCR on peritoneal cells from mice injected nine times over 3 weeks with PBS or MIF proteins. (B) RELM-alpha transcript levels in the same peritoneal cell samples. (C) Arginase-1 transcript levels in the same peritoneal cell samples. (D) Eosinophil induction in the peritoneal cavity of mice injected nine times over 3 weeks with PBS or MIF proteins. (A-C) Expression levels are calculated in arbitrary units relative to a housekeeping gene control (beta-actin). Results are representative of two experiments with similar results. No NOS-2 transcripts were detected in the same samples. Data were analyzed by one-way ANOVA, followed by Bonferoni's post test. *, P < 0.05; ***, P < 0.01.
###end p 144

